Biomax Buys Eudaptic’s Viscovery Group To Boost Data-Mining Muscle for BioXM | GenomeWeb
Martinsried, Germany-based Biomax has added new data-mining ammo to its BioXM knowledge-management platform by nabbing the Viscovery product line from Eudaptics Software of Vienna, Austria.
 
Eudaptics spun out its flagship Viscovery business earlier this month and will remain a holding company. Viscovery’s six staffers will remain in Vienna and will operate as a subsidiary of Biomax under the name of Viscovery Software. The acquisition brings Biomax’s total headcount to 70.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.